
    
      This is a double-blind, prospective, randomized, placebo-controlled trial to determine the
      tolerability, efficacy, safety and dose range of intramyocardial injections of adult
      autologous CD34+ cells mobilized with granulocyte colony stimulating factor (G-CSF) for the
      reduction of angina episodes in patients with refractory chronic myocardial ischemia.
    
  